pharmaphorum November 17, 2023
Janet Woodcock will bring a career at the FDA spanning almost four decades to a close next year, retiring from her current role as principal deputy commissioner of the regulator.
Woodcock (75), who led the FDA as acting commissioner during the COVID-19 pandemic and was replaced on a permanent basis by Robert Califf in February 2022, is planning to step down at the end of January and has said she will not be looking for any roles outside the FDA.
She has worked at the agency since 1986, and served as director of the Center for Drug Evaluation and Research (CDER) for more than a decade on two occasions, initially between 1994 and 2004 and then from 2007 to 2020,...
Today's Sponsors
Today's Sponsor